Ömer Yüceer

Ömer Yüceer

Auto-generated profile, based on publicly available information

Ömer Yüceer

Department of Emergency Medicine, Niğde Ömer Halisdemir Training and Research Hospital, Niğde, Turkey

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 April 2024 in Journal of Advances in VetBio Science and Techniques
Verified
Journal Article
Open access
PDF file
TDturgut dolanbay
turgut dolanbay
MMMustafa Makav
Mustafa Makav
AVAbdussamed Vural
Abdussamed Vural
MCMustafa Oguz Cumaoglu
Mustafa Oguz Cumaoglu
ÖYÖmer Yüceer
Ömer Yüceer
HMHatice Tetik Metin
Hatice Tetik Metin
Letrozole (LTZ), is an aromatase inhibitor, that has been widely used in a variety of diseases such as polycystic ovary syndrome, endometriosis, and breast cancer. LTZ is received via the oral route and metabolized in the liver. Therefore, LTZ may have toxic effects like other drugs metabolized in the liver. Based on this, our study aimed to investigate the effect of LTZ on liver function and biochemical parameters. For this purpose, 16 Wistar albino female rats were divided into two groups (n=8): Control and LTZ respectively. The rats in the letrozole group were administered with 2 mL/kg LTZ by oral gavage once a day for 21 days. The Control group received the vehicle once a day for 21 days. Blood samples were collected on the 22nd day of the experiment. Alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma-glutamyl transferase (GGT), lactate dehydrogenase (LDH), albumin (ALB), alkaline phosphatase (ALP), direct bilirubin and total bilirubin were measured. Biochemical analysis indicated that ALT, AST, LDH, ALP, and total bilirubin levels were significantly higher in the LTZ administrated group compared to the Control. ALB levels decreased in the LTZ group. In conclusion, it was determined that LTZ has toxic and detrimental effects on the liver. We suggested that long-term LTZ administrated patients should be under control against liver damage and may have liver supporting adjuvant therapies for robust liver functions.

3 March 2026 in BMC Cardiovascular Disorders
Verified
Journal Article
Open access
AVAbdussamed Vural
Abdussamed Vural
TDturgut dolanbay
turgut dolanbay
MCMustafa Oguz Cumaoglu
Mustafa Oguz Cumaoglu
ZEZafer Elbasan
Zafer Elbasan
OYOmer Yuceer
Omer Yuceer
SSSabri Sekme
Sabri Sekme
Acute myocardial infarction (AMI) in very young adults (≤ 35 years) represents a distinct clinical entity with limited evidence. This study aimed to characterize metabolic risk factors differentiating young AMI patients from clinic-based controls. This single-center retrospective case–control study included 62 consecutive young adults (aged 18–35 years) with confirmed AMI and 60 clinic-based controls selected from cardiology outpatient clinics during the same study period. Controls were selected using age (± 2 years) and sex restrictions to ensure group-level comparability with the AMI cohort. Metabolic parameters, including body mass index (BMI), LDL cholesterol, and blood glucose, were compared between groups. Effect sizes (Cohen’s d) were calculated to assess clinical significance. Multivariable logistic regression was performed to identify independent predictors of AMI. Correlation analyses (Pearson or Spearman, as appropriate) were performed to examine relationships between metabolic markers. Young AMI patients demonstrated a significantly more unfavorable metabolic profile than controls: median BMI (26.5 vs. 23.9 kg/m², p < 0.001), LDL cholesterol (136.5 vs. 108.0 mg/dL, p = 0.002), and blood glucose (120.0 vs. 95.0 mg/dL, p < 0.001). All three metabolic parameters showed large effect sizes (d > 1.0), indicating clinically substantial differences. In multivariable analysis, BMI (adjusted OR 1.28 per kg/m², 95% CI 1.08–1.52), LDL cholesterol (adjusted OR 1.14 per 10 mg/dL, 95% CI 1.01–1.29), and blood glucose (adjusted OR 1.16 per 10 mg/dL, 95% CI 1.05–1.29) remained independently associated with AMI risk. LDL cholesterol showed a statistically significant, albeit weak, positive association with peak troponin levels (ρ = 0.296, p = 0.020). Among AMI cases, STEMI patients exhibited higher acute glucose levels than NSTEMI patients (p = 0.004). Very young adults (≤ 35 years) with AMI exhibit markedly elevated BMI, LDL cholesterol, and glucose levels compared to age- and sex-comparable controls with large effect sizes supporting clinical significance. Multivariable analysis confirmed independent associations for all three metabolic parameters. These traditional modifiable risk factors continue to be strongly associated with early myocardial infarction, emphasizing the importance of aggressive metabolic screening and early prevention strategies in very young populations. The online version contains supplementary material available at 10.1186/s12872-026-05662-7.

1 January 2024 in Urology Research and Practice
Verified
Journal Article
Open access
KYKazım Yelsel
Kazım Yelsel
EAErgün Alma
Ergün Alma
ÖYÖmer Yüceer
Ömer Yüceer
ZTZeynel Abidin Taş
Zeynel Abidin Taş
BABerna Totan Ateş
Berna Totan Ateş
AAAli Ayyıldız
Ali Ayyıldız
Objective: The aim was to evaluate the effect of yellow and red centaury St. John’s Wort (St. JW) oil on inflammation and urethral fibrosis development in a rat urethral trauma model. Methods: A total of 24 male rats were divided into 5 groups. No urethral damage was induced in the sham group. The urethras of all rats in the other groups was traumatized at 6 o’clock with a specially designed urethrotome blade. Group 1 was administered 0.5 cc of St. JW oil once daily for 15 days. Group 2 was administered 0.5 cc of red centaury oil intraurethrally once daily for 15 days. The traumatized rats in Group 3 were not treated (St. JW and red centaury oil were not administered). St. JW oil was administered to 3 rats in the Sham 1 group (Group 4), and red centaury oil was administered to 3 rats in the Sham 2 group (Group 5). A 20-G/32-mm intravenous cannula sheath was used for intraurethral administration. On the 15th day, rats were sacrificed and penectomy was performed for histologic evaluation. Results: Spongiofibrosis, mucosal inflammation, and congestion were significantly decreased in the yellow St. JW oil group when compared with the red centaury oil group and the untreated group (group to which neither St. JW nor red centaury oil was administered). Conclusion: In this study, intraurethral administration of yellow St. JW oil was found to significantly reduce mucosal inflammation, spongiofibrosis, and obstruction after urethral trauma. According to the results of this study, we think that St. JW oil may be a promising option in the treatment of urethral stricture. Cite this article as: Yelsel K, Alma E, Yüceer Ö, et al. The effect of St. John’s Wort oil on urethral stricture: an experimental study in rat model. Urol Res Pract. 2024;50(4):261-266.

1 June 2026 in International Journal of General Medicine
Verified
Journal Article
Open access
ÖYÖmer Yüceer
Ömer Yüceer
AVAbdussamed Vural
Abdussamed Vural
Stroke remains a leading cause of in-hospital mortality worldwide. Routinely available laboratory biomarkers obtained at emergency department admission may facilitate early risk stratification. This study aimed to evaluate the associations between admission serum uric acid (SUA), troponin, and C-reactive protein (CRP) levels and in-hospital mortality in patients with acute stroke. This retrospective single-center study included 403 adults diagnosed with acute ischemic or hemorrhagic stroke between January 1, 2019, and January 1, 2022. Demographic data, comorbidities, and admission laboratory findings were extracted from electronic hospital records. Univariate and multivariable logistic regression analyses were performed to identify independent predictors of in-hospital mortality. Receiver operating characteristic (ROC) analysis was used to evaluate discriminatory performance. Of 403 patients (mean age 73.8 ± 12.4 years; 54.8% male), 16.6% (n=67) died during hospitalization. Non-survivors were significantly older and had higher admission SUA, troponin, and CRP levels (all p14 ng/L (OR: 2.23; 95% CI: 1.21–4.01; p=0.012), CRP >5 mg/L (OR: 2.93; 95% CI: 1.59–5.67; p=0.001), and SUA >7 mg/dL (OR: 1.93; 95% CI: 1.04–3.53; p=0.041) were independently associated with in-hospital mortality. CRP showed the highest discriminatory performance (AUC: 0.77), while troponin (AUC: 0.67) and SUA (AUC: 0.66) demonstrated limited discriminatory ability. Admission CRP, troponin, and SUA levels were independently associated with in-hospital mortality in acute stroke patients. However, given their moderate discriminatory performance and the absence of standardized stroke severity scores, these biomarkers should be interpreted as supplementary risk indicators rather than standalone prognostic tools. Prospective multicenter studies incorporating stroke severity scales are warranted.

25 August 2024 in Interdisciplinary Medical Journal
Verified
Journal Article
Closed access
ÖYÖmer Yüceer
Ömer Yüceer
AVAbdussamed Vural
Abdussamed Vural
TDturgut dolanbay
turgut dolanbay
MCMustafa Oguz Cumaoğlu
Mustafa Oguz Cumaoğlu
MDMustafa Doğan
Mustafa Doğan
MÖMustafa Özçelik
Mustafa Özçelik
Objective: The present study investigated the relationship between epistaxis and age, sex, hemogram and coagulation parameters and aimed to set a standard in the approach to epistaxis. Materials and Methods: Patients over the age of 18 who presented due to epistaxis between July 1, 2022, and July 1, 2023, were included in this study, and the files of these patients were examined retrospectively. Patients with trauma and chronic hypertension (HT), individuals with diseases that might predispose to bleeding and with a history of bleeding-related drug use such as coumadin derivatives or individuals with malignancy, those who were found to have active infection during the study, patients who were determined to be in the postoperative period, patients whose blood pressure was determined to be above 140/90 mmHg at the time of admission, and those who were found to have blood samples with hemolysis detected in the file records were excluded from the study. Results: The data of a total of 100 patients, including 62 male and 38 female patients, who presented with complaints of epistaxis, were examined. It was found that more patients at older ages presented to emergency departments with complaints of epistaxis and the number of male patients with epistaxis was higher than female patients. It was concluded that headache is the most common early symptom before spontaneous bleeding in nosebleeds, which are more common in older adults, and platelet values, which are negatively correlated with age and positive correlated with activated partial thromboplastin time ( aPTT ) and hemoglobin (HGB ) are an essential marker for nosebleeds. Furthermore, it was concluded that it is meaningless to check coagulation parameters in patients who are not coumadinized, while checking the hemogram remains important.

22 March 2019 in Demiroğlu Bilim University Florence Nightingale Journal of Medicine
Verified
Journal Article
Open access
PDF file
ÖYÖmer Yüceer
Ömer Yüceer
ADAli Duman
Ali Duman
AAAyhan Akoz
Ayhan Akoz
SÖSerhat Örün
Serhat Örün
KTKenan Ahmet Türkdoğan
Kenan Ahmet Türkdoğan
Objectives: This study aims to examine patients with gastrointestinal system (GIS) bleeding and evaluate the appropriate treatment methods. Materials and methods: This retrospective study included 164 patients (99 males, 65 females; mean age 66.87 years; range, 21 to 97 years) with GIS bleeding. Demographic characteristics, complaints, habits, duration of hospitalization, and medications used by patients were determined from the files. The effects of hemogram, biochemistry, coagulation, age, gender, and endoscopic findings on mortality were investigated. The effects of endoscopic findings and presence of additional diseases on blood transfusion and other treatment modalities, duration of hospitalization, and mortality were also investigated. Results: Of the patients with GIS bleeding, 48.8% applied to our hospital with complaint of melena, 24.4% of melena and hematemesis, 15.8% of hematemesis, 6.1% of hematochezia, and 4.9% of syncope. Mean duration of hospitalization was 4.65±4.14 days. While endoscopy was performed in 98.2% of the patients, endoscopy could not be performed in 1.8% of the patients who could not be stabilized. Conclusion: Bleeding control is important to reduce mortality in patients with GIS bleeding. We believe that particularly endoscopic intervention contributes positively in reducing such patients' mortality and morbidity.